Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

FOXO TECHNOLOGIES INC. (FOXO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

FOXO TECHNOLOGIES INC. (FOXO), most recent 12 months reported: revenue $17.86M, net loss $4.6M, free cash flow -$3.93M. Latest balance sheet on file: liquid cash $58.41K. From SEC filings. Others in Services-Commercial Physical & Biological Research: Medpace Holdings, Inc. · NRC Health · OMNIAB, INC. · MaxCyte, Inc. · bioAffinity Technologies, Inc. · ABSCI CORP · ONEMEDNET CORPORATION · iSpecimen Inc.

Stock screener

Watchlist